A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

YMAB Insider Trading (Y-mAbs Therapeutics)

Insider Ownership Percentage: 20.61%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,716,067.33

Y-mAbs Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Y-mAbs Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Y-mAbs Therapeutics Share Price & Price History

Current Price: $18.30
Price Change: Price Increase of +0.9 (5.17%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for YMAB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

Y-mAbs Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2022Bo KruseCFOSell4,000$7.85$31,400.00View SEC Filing Icon  
2/9/2022Thomas GadInsiderSell64,276$6.96$447,360.96View SEC Filing Icon  
2/7/2022Thomas GadInsiderSell91,031$7.59$690,925.29View SEC Filing Icon  
2/4/2022Bo KruseCFOSell4,000$7.97$31,880.00View SEC Filing Icon  
2/3/2022Thomas GadInsiderSell35,060$7.90$276,974.00View SEC Filing Icon  
2/1/2022Thomas GadInsiderSell8,000$10.15$81,200.00View SEC Filing Icon  
1/24/2022Bo KruseCFOSell4,000$9.84$39,360.00View SEC Filing Icon  
1/24/2022Thomas GadInsiderSell88,055$10.63$936,024.65View SEC Filing Icon  
1/20/2022Thomas GadInsiderSell112,767$11.33$1,277,650.11View SEC Filing Icon  
1/18/2022Thomas GadInsiderSell8,000$11.54$92,320.00View SEC Filing Icon  
1/4/2022Bo KruseCFOSell4,000$17.12$68,480.00View SEC Filing Icon  
12/22/2021Bo KruseCFOSell4,000$16.36$65,440.00View SEC Filing Icon  
12/6/2021Bo KruseCFOSell4,000$16.35$65,400.00View SEC Filing Icon  
12/6/2021Thomas GadInsiderSell44,000$16.48$725,120.00View SEC Filing Icon  
11/29/2021Thomas GadInsiderSell22,437$17.16$385,018.92View SEC Filing Icon  
11/23/2021Thomas GadInsiderSell50,000$17.06$853,000.00View SEC Filing Icon  
11/22/2021Bo KruseCFOSell4,000$18.09$72,360.00View SEC Filing Icon  
11/16/2021Thomas GadInsiderSell4,000$19.33$77,320.00View SEC Filing Icon  
10/29/2021Thomas GadInsiderSell4,000$24.82$99,280.00View SEC Filing Icon  
10/22/2021Bo KruseCFOSell4,000$25.94$103,760.00View SEC Filing Icon  
10/15/2021Thomas GadInsiderSell4,000$27.20$108,800.00View SEC Filing Icon  
10/4/2021Bo KruseCFOSell4,000$28.78$115,120.00View SEC Filing Icon  
9/30/2021Thomas GadInsiderSell4,000$28.26$113,040.00View SEC Filing Icon  
9/22/2021Bo KruseCFOSell4,000$30.82$123,280.00View SEC Filing Icon  
9/15/2021Thomas GadInsiderSell4,000$33.64$134,560.00View SEC Filing Icon  
9/7/2021Bo KruseCFOSell4,000$32.03$128,120.00225,077View SEC Filing Icon  
9/2/2021Thomas GadInsiderSell50,000$33.18$1,659,000.0050,000View SEC Filing Icon  
8/23/2021Bo KruseCFOSell4,000$28.60$114,400.00View SEC Filing Icon  
8/16/2021Thomas GadInsiderSell26,111$29.30$765,052.30View SEC Filing Icon  
8/13/2021Thomas GadInsiderSell1,110$31.01$34,421.10View SEC Filing Icon  
8/12/2021Vignesh RajahCMOBuy1,374$29.95$41,151.30View SEC Filing Icon  
8/4/2021Bo KruseCFOSell4,000$33.72$134,880.00View SEC Filing Icon  
7/22/2021Bo KruseCFOSell4,000$34.50$138,000.00View SEC Filing Icon  
7/22/2021Bo KruseCFOSell4,000$34.50$138,000.00View SEC Filing Icon  
7/20/2021Thomas GadInsiderSell4,000$32.47$129,880.00View SEC Filing Icon  
7/6/2021Bo KruseCFOSell4,000$34.15$136,600.00View SEC Filing Icon  
6/22/2021Bo KruseCFOSell4,000$36.17$144,680.00245,077View SEC Filing Icon  
6/14/2021Thomas GadInsiderSell4,000$35.80$143,200.00View SEC Filing Icon  
6/9/2021Biotech Aps WgDirectorSell116,700$36.19$4,223,373.004,306,394View SEC Filing Icon  
6/7/2021Biotech Aps WgMajor ShareholderSell72,400$34.15$2,472,460.004,306,394View SEC Filing Icon  
6/4/2021Biotech Aps WgMajor ShareholderSell3,841$34.03$130,709.234,415,935View SEC Filing Icon  
6/4/2021Bo KruseCFOSell4,000$33.48$133,920.00249,077View SEC Filing Icon  
6/3/2021Johan Wedell-WedellsborgDirectorSell30,666$33.19$1,017,804.544,415,935View SEC Filing Icon  
6/1/2021Johan Wedell-WedellsborgDirectorSell6,864$35.57$244,152.484,453,465View SEC Filing Icon  
5/28/2021Johan Wedell-WedellsborgDirectorSell25,000$36.34$908,500.004,453,465View SEC Filing Icon  
5/28/2021Thomas GadInsiderSell4,000$36.95$147,800.00View SEC Filing Icon  
5/24/2021Bo KruseCFOSell4,000$35.61$142,440.00253,077View SEC Filing Icon  
4/26/2021Thomas GadInsiderSell7,000$27.96$195,720.007,000View SEC Filing Icon  
4/12/2021Thomas GadInsiderSell7,000$26.61$186,270.007,000View SEC Filing Icon  
3/15/2021Thomas GadInsiderSell7,000$36.79$257,530.007,000View SEC Filing Icon  
1/19/2021David N GillDirectorSell2,000$46.52$93,040.002,000View SEC Filing Icon  
1/19/2021Thomas GadInsiderSell7,000$46.51$325,570.007,000View SEC Filing Icon  
1/5/2021Thomas GadInsiderSell7,000$49.36$345,520.007,000View SEC Filing Icon  
12/28/2020Thomas GadInsiderSell7,000$51.98$363,860.007,000View SEC Filing Icon  
12/16/2020Thomas GadInsiderSell7,000$53.01$371,070.007,000View SEC Filing Icon  
12/14/2020Thomas GadInsiderSell4,000$52.89$211,560.00View SEC Filing Icon  
12/10/2020Thomas GadInsiderSell50,000$50.75$2,537,500.0050,000View SEC Filing Icon  
12/2/2020Pedro Claus Juan Moller-SanCEOSell40,734$51.27$2,088,432.1815,625View SEC Filing Icon  
12/2/2020Vignesh RajahCMOBuy233$51.03$11,889.99View SEC Filing Icon  
12/1/2020Thomas GadChairmanSell4,000$51.42$205,680.00View SEC Filing Icon  
11/17/2020Vignesh RajahCMOBuy1,464$45.74$66,963.36View SEC Filing Icon  
11/3/2020David N GillDirectorSell4,000$45.00$180,000.004,000View SEC Filing Icon  
10/15/2020Thomas GadChairmanSell4,000$39.15$156,600.00View SEC Filing Icon  
10/1/2020Thomas GadChairmanSell4,000$38.88$155,520.00View SEC Filing Icon  
9/14/2020Thomas GadChairmanSell22,569$41.00$925,329.0013,860View SEC Filing Icon  
9/11/2020Thomas GadChairmanSell13,571$40.33$547,318.4313,860View SEC Filing Icon  
9/1/2020Thomas GadChairmanSell4,000$41.60$166,400.00View SEC Filing Icon  
8/17/2020Thomas GadChairmanSell4,000$40.35$161,400.00View SEC Filing Icon  
8/11/2020Thomas GadChairmanSell37,000$40.06$1,482,220.00View SEC Filing Icon  
7/15/2020Thomas GadChairmanSell4,000$40.06$160,240.00View SEC Filing Icon  
6/15/2020Thomas GadChairmanSell4,000$43.45$173,800.00View SEC Filing Icon  
6/4/2020Thomas GadChairmanSell4,000$41.61$166,440.00View SEC Filing Icon  
5/26/2020Mahiuddin AhmedVPSell50,000$39.38$1,969,000.00150,000View SEC Filing Icon  
5/13/2020Bo KruseCFOSell14,724$37.86$557,450.64285,276View SEC Filing Icon  
5/13/2020Pedro Claus Juan Moller-SanCEOSell60,846$37.75$2,296,936.5015,625View SEC Filing Icon  
5/12/2020Mahiuddin AhmedVPSell20,000$39.19$783,800.00240,000View SEC Filing Icon  
5/12/2020Thomas GadChairmanSell50,000$39.04$1,952,000.00View SEC Filing Icon  
4/13/2020Thomas GadChairmanSell4,000$29.43$117,720.00View SEC Filing Icon  
3/17/2020Pedro Claus Juan Moller-SanCEOBuy1,900$17.22$32,718.0015,625View SEC Filing Icon  
3/16/2020Thomas GadChairmanSell4,000$18.01$72,040.00View SEC Filing Icon  
2/10/2020Thomas GadChairmanSell4,000$33.03$132,120.00View SEC Filing Icon  
1/27/2020Thomas GadChairmanSell4,000$35.06$140,240.00View SEC Filing Icon  
1/13/2020Thomas GadChairmanSell4,000$30.90$123,600.00View SEC Filing Icon  
12/16/2019Thomas GadChairmanSell4,000$31.54$126,160.00View SEC Filing Icon  
12/2/2019Thomas GadChairmanSell4,000$32.48$129,920.00View SEC Filing Icon  
11/18/2019Thomas GadChairmanSell4,000$28.85$115,400.00
11/4/2019Thomas GadChairmanSell4,000$30.01$120,040.00
10/30/2019James HealyDirectorBuy90,000$29.79$2,681,100.00
10/21/2019Thomas GadChairmanSell4,000$31.65$126,600.00
10/18/2019Thomas GadCEOSell7,250$16.71$121,147.50
10/7/2019Thomas GadChairmanSell4,000$25.21$100,840.00
9/16/2019Thomas GadChairmanSell4,000$30.59$122,360.00
9/6/2019Johan Wedell-WedellsborgDirectorSell17,243$27.00$465,561.00
9/3/2019Thomas GadChairmanSell4,000$25.77$103,080.00View SEC Filing Icon  
8/30/2019Johan Wedell-WedellsborgDirectorSell89,166$26.58$2,370,032.28View SEC Filing Icon  
8/28/2019Johan Wedell-WedellsborgDirectorSell49,357$27.08$1,336,587.56View SEC Filing Icon  
8/21/2019Johan Wedell-WedellsborgDirectorSell168,244$27.57$4,638,487.08View SEC Filing Icon  
8/19/2019Thomas GadInsiderSell4,000$27.70$110,800.00View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for Y-mAbs Therapeutics (NASDAQ:YMAB)

60.50% of Y-mAbs Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at YMAB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Y-mAbs Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Zurcher Kantonalbank Zurich Cantonalbank 6,513$99K0.0%+248.7%0.015%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC149,800$2.27M0.0%+64.6%0.343%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp333,098$5.04M0.0%+1.8%0.762%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc42,152$0.64M0.0%+871.2%0.096%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG20,924$0.32M0.0%+8.6%0.048%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC50,596$0.77M0.0%-63.9%0.116%Search for SEC Filing on Google Icon
8/12/2022FMR LLC1,970,851$29.82M0.0%+0.0%4.508%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA7,980$0.12M0.0%+172.5%0.018%Search for SEC Filing on Google Icon
8/12/2022Brandywine Global Investment Management LLC21,300$0.32M0.0%-12.7%0.049%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers43,511$0.66M0.0%+20.6%0.100%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG70,336$1.06M0.0%-76.9%0.161%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG25,569$0.39M0.0%-80.9%0.058%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.32,664$0.49M0.0%-22.8%0.075%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.10,595$0.16M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank77,100$1.17M0.0%+24.4%0.176%Search for SEC Filing on Google Icon
8/9/2022Lazard Asset Management LLC5,655$85K0.0%N/A0.013%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC416,140$6.30M0.2%N/A0.952%Search for SEC Filing on Google Icon
8/8/2022Rice Hall James & Associates LLC91,898$1.39M0.1%+1.7%0.210%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System15,096$0.23M0.0%+35.3%0.035%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.36,054$0.55M0.0%+36.3%0.082%Search for SEC Filing on Google Icon
7/29/2022SG Americas Securities LLC18,217$0.28M0.0%N/A0.042%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.11,186$0.17M0.0%N/A0.026%Search for SEC Filing on Google Icon
7/25/2022Allspring Global Investments Holdings LLC4,628$70K0.0%-74.6%0.011%Search for SEC Filing on Google Icon
7/25/2022Strs Ohio26,600$0.40M0.0%+6.0%0.061%Search for SEC Filing on Google Icon
7/8/2022DnB Asset Management AS13,399$0.20M0.0%N/A0.031%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank5,706$68K0.0%N/A0.013%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE398,823$4.74M0.0%+386.8%0.912%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA2,928$35K0.0%-67.8%0.007%Search for SEC Filing on Google Icon
5/17/2022Polar Capital Holdings Plc2,877,671$34.19M0.2%+108.9%6.584%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada9,471$0.11M0.0%-25.6%0.022%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System37,293$0.44M0.0%-9.3%0.085%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.126,111$1.50M0.0%-42.0%0.288%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP1,910,578$22.70M0.0%-55.3%4.371%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,308,782$27.43M0.0%+58.5%5.282%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG134,177$1.59M0.0%+108.2%0.307%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC91,000$1.08M0.0%-7.7%0.208%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp327,253$3.89M0.0%-4.9%0.749%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.233,756$2.78M0.0%-4.5%0.535%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.17,350$0.21M0.0%-6.6%0.040%Search for SEC Filing on Google Icon
5/13/2022Ergoteles LLC23,063$0.27M0.0%+24.2%0.053%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.172,584$2.05M0.0%-6.0%0.395%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,794,510$21.32M0.0%-1.2%4.105%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP183,368$2.18M0.0%-4.4%0.420%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.2,945,094$34.99M0.0%+6.4%6.737%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY2,305$27K0.0%-75.9%0.005%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC20,683$0.25M0.0%+54.2%0.047%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.30,402$0.36M0.0%-55.1%0.070%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.26,443$0.31M0.0%N/A0.060%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.42,322$0.50M0.0%+12.6%0.097%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC11,069$0.13M0.0%-19.7%0.025%Search for SEC Filing on Google Icon
5/10/2022CNA Financial Corp25,450$0.30M0.1%+39.6%0.058%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank62,000$0.74M0.0%+8.2%0.142%Search for SEC Filing on Google Icon
5/5/2022Rice Hall James & Associates LLC90,375$1.07M0.0%+7.1%0.207%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund24,579$0.29M0.0%-89.6%0.056%Search for SEC Filing on Google Icon
4/28/2022DekaBank Deutsche Girozentrale14,400$0.17M0.0%+9.9%0.033%Search for SEC Filing on Google Icon
4/21/2022Strs Ohio25,100$0.30M0.0%N/A0.057%Search for SEC Filing on Google Icon
2/15/2022Ashford Capital Management Inc.226,180$3.67M0.4%-50.0%0.518%Search for SEC Filing on Google Icon
2/14/2022Lombard Odier Asset Management Switzerland SA385,440$6.25M0.4%+9.2%0.883%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC23,646$0.38M0.1%+88.0%0.054%Search for SEC Filing on Google Icon
2/14/2022Rice Hall James & Associates LLC84,395$1.37M0.0%-15.0%0.193%Search for SEC Filing on Google Icon
2/14/2022Alliancebernstein L.P.1,942,334$31.49M0.0%+37.0%4.450%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.310,494$5.03M0.5%+16.9%0.711%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP69,311$1.12M0.1%N/A0.159%Search for SEC Filing on Google Icon
2/11/2022CNA Financial Corp18,230$0.30M0.1%+32.5%0.042%Search for SEC Filing on Google Icon
2/11/2022Bioimpact Capital LLC446,457$7.24M1.3%-1.4%1.023%Search for SEC Filing on Google Icon
2/11/2022Allianz Asset Management GmbH29,754$0.48M0.0%-20.3%0.068%Search for SEC Filing on Google Icon
2/10/2022Candriam Luxembourg S.C.A.183,692$2.98M0.0%+3.1%0.421%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd15,577$0.25M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC76,576$1.24M0.0%+88.7%0.175%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.67,755$1.10M0.0%+113.4%0.155%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA9,100$0.15M0.0%+41.1%0.021%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.50,503$0.82M0.0%-5.4%0.116%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP191,802$3.11M0.0%+52.8%0.439%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp343,987$5.58M0.0%-0.9%0.788%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC15,020$0.24M0.0%-41.8%0.034%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.4,159$67K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund236,284$3.83M0.0%-21.8%0.541%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd15,577$0.25M0.0%N/A0.036%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC15,063$0.24M0.0%N/A0.035%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.64,404$1.04M0.0%+77.5%0.148%Search for SEC Filing on Google Icon
1/12/2022DNB Asset Management AS13,367$0.22M0.0%+6.4%0.031%Search for SEC Filing on Google Icon
11/16/2021Migdal Insurance & Financial Holdings Ltd.1,720$49K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/16/2021Brookfield Asset Management Inc.179,236$5.12M0.0%+7.5%0.411%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP49,000$1.40M0.0%-63.8%0.112%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP4,278,097$122.10M0.0%-3.8%9.802%Search for SEC Filing on Google Icon
11/16/2021BioImpact Capital LLC452,970$12.93M2.0%+34.3%1.038%Search for SEC Filing on Google Icon
11/15/2021Point72 Hong Kong Ltd995$28K0.0%N/A0.002%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC14,884$0.43M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System40,232$1.15M0.0%-16.5%0.092%Search for SEC Filing on Google Icon
11/15/2021Oracle Investment Management Inc.315,642$9.01M1.1%+5.0%0.723%Search for SEC Filing on Google Icon
11/15/2021Virtus ETF Advisers LLC12,578$0.36M0.2%-8.4%0.029%Search for SEC Filing on Google Icon
11/15/2021Polar Capital Holdings Plc1,154,961$32.96M0.1%+97.1%2.646%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP125,522$3.58M0.0%N/A0.288%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc6,043$0.17M0.0%-73.3%0.014%Search for SEC Filing on Google Icon
11/15/2021Lombard Odier Asset Management Switzerland SA352,839$10.07M0.6%+10.3%0.808%Search for SEC Filing on Google Icon
11/12/2021Brandywine Global Investment Management LLC32,537$0.93M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/12/2021The Manufacturers Life Insurance Company18,856$0.54M0.0%-6.6%0.043%Search for SEC Filing on Google Icon
11/12/2021Credit Suisse AG16,942$0.48M0.0%+8.8%0.039%Search for SEC Filing on Google Icon
11/12/2021CNA Financial Corp13,760$0.39M0.1%+3.5%0.032%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC577,111$16.47M0.0%+4.7%1.322%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Y-mAbs Therapeutics logo
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developing DANYELZA that is in Phase II clinical studies for the treatment of patients with first-line neuroblastoma, third-line neuroblastoma, and in relapsed osteosarcoma; GD2-GD3 vaccine that is in Phase II clinical trial for the treatment of Stage 4 high-risk neuroblastoma; and Omburtamab, a murine monoclonal antibody that is in clinical trials for the treatment of central nervous system/ leptomeningeal metastases from neuroblastoma, desmoplastic small round cell tumor, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. In addition, it is developing Nivatrotamab for the treatment of small cell lung cancer, as well as is in Phase I/II trial for the treatment of refractory GD2 positive adult and pediatric solid tumors; and Lu-omburtamab-DTPA that is in Phase I clinical development for the treatment of medulloblastoma and B7-H3 positive leptomeningeal metastases from solid tumors. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Read More on Y-mAbs Therapeutics

Today's Range

Now: $18.30
Low: $17.15
High: $18.47

50 Day Range

MA: $15.83
Low: $10.80
High: $19.67

52 Week Range

Now: $18.30
Low: $6.50
High: $34.60

Volume

228,675 shs

Average Volume

270,032 shs

Market Capitalization

$800.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top insider shareholders include:
  1. Johan Wedell-Wedellsborg (Director)
  2. Biotech Aps Wg (Major Shareholder)
  3. Biotech Aps Wg (Director)
  4. Bo Kruse (CFO)
  5. Thomas Gad (Insider)
  6. Pedro Claus Juan Moller-San (CEO)
  7. Thomas Gad (Chairman)
  8. David N Gill (Director)
  9. Vignesh Rajah (CMO)
Learn More about top insider investors at Y-mAbs Therapeutics.

Who are the major institutional investors of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top institutional shareholders include:
  1. FMR LLC — 4.51%
  2. Walleye Capital LLC — 0.95%
  3. Northern Trust Corp — 0.76%
  4. Renaissance Technologies LLC — 0.34%
  5. Rice Hall James & Associates LLC — 0.21%
  6. Swiss National Bank — 0.18%
Learn More about top institutional investors of Y-mAbs Therapeutics stock.

Which major investors are selling Y-mAbs Therapeutics stock?

During the previous quarter, YMAB stock was sold by these institutional investors:
  1. Deutsche Bank AG
  2. UBS Group AG
  3. Rafferty Asset Management LLC
  4. Allspring Global Investments Holdings LLC
  5. JPMorgan Chase & Co.
  6. Brandywine Global Investment Management LLC
During the previous year, company insiders that have sold Y-mAbs Therapeutics company stock include:
  1. Johan Wedell-Wedellsborg (Director)
  2. Biotech Aps Wg (Major Shareholder)
Learn More investors selling Y-mAbs Therapeutics stock.

Which major investors are buying Y-mAbs Therapeutics stock?

Within the last quarter, YMAB stock was purchased by institutional investors including:
  1. Walleye Capital LLC
  2. Renaissance Technologies LLC
  3. Ensign Peak Advisors Inc
  4. SG Americas Securities LLC
  5. Swiss National Bank
  6. DnB Asset Management AS
  7. Mirae Asset Global Investments Co. Ltd.
  8. Principal Financial Group Inc.
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.